These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16831930)

  • 1. Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS.
    Pan G; Yang Z; Ballinger SW; McDonald JM
    Ann N Y Acad Sci; 2006 Apr; 1068():297-308. PubMed ID: 16831930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of anitiretroviral therapy on bone tissue metabolism in patients with HIV].
    Olczak A; Pawłowska M; Drózdz W
    Przegl Epidemiol; 2008; 62(1):155-62. PubMed ID: 18536239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
    Madeddu G; Spanu A; Solinas P; Babudieri S; Calia GM; Lovigu C; Mannazzu M; Nuvoli S; Piras B; Bagella P; Mura MS; Madeddu G
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4576-89. PubMed ID: 26698255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
    Su YB; Xie J; Han Y; Qiu ZF; Li YL; Song XJ; Yu W; Li TS
    Zhonghua Yi Xue Za Zhi; 2012 May; 92(17):1155-8. PubMed ID: 22883000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multifactorial relations between HIV, HAART and bone metabolism].
    Borderi M
    Infez Med; 2006 Sep; 14(3):117-24. PubMed ID: 17127825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.
    Aydın OA; Karaosmanoglu HK; Karahasanoglu R; Tahmaz M; Nazlıcan O
    Braz J Infect Dis; 2013; 17(6):707-11. PubMed ID: 24076108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.
    Madeddu G; Spanu A; Solinas P; Calia GM; Lovigu C; Chessa F; Mannazzu M; Falchi A; Mura MS; Madeddu G
    Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):39-48. PubMed ID: 15195003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy.
    Mora S; Sala N; Bricalli D; Zuin G; Chiumello G; Viganò A
    AIDS; 2001 Sep; 15(14):1823-9. PubMed ID: 11579244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART.
    Landonio S; Quirino T; Bonfanti P; Gabris A; Boccassini L; Gulisano C; Vulpio L; Ricci E; Carrabba M; Vigevani GM
    Biomed Pharmacother; 2004 Nov; 58(9):505-8. PubMed ID: 15511607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients].
    Guo FP; Yu XB; Luo L; Han Y; Qiu ZF; Zuo LY; Li YL; Yu W; Li TS
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):649-52. PubMed ID: 20979781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients.
    Fernández-Rivera J; García R; Lozano F; Macías J; García-García JA; Mira JA; Corzo JE; Gómez-Mateos J; Rueda A; Sánchez-Burson J; Pineda JA
    HIV Clin Trials; 2003; 4(5):337-46. PubMed ID: 14583850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
    Carr A; Miller J; Eisman JA; Cooper DA
    AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
    Krikke M; Klomberg RCW; van der Veer E; Tesselaar K; Verhaar HJJ; Hoepelman AIM; Arends JE
    Neth J Med; 2017 May; 75(4):138-144. PubMed ID: 28522769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy.
    Guaraldi G; Ventura P; Albuzza M; Orlando G; Bedini A; Amorico G; Esposito R
    AIDS; 2001 Jan; 15(1):137-8. PubMed ID: 11192861
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV infection--a risk factor for osteoporosis.
    Thomas J; Doherty SM
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):281-91. PubMed ID: 12843738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of HIV Infection and Antiretroviral Therapy on Bone Homeostasis.
    Delpino MV; Quarleri J
    Front Endocrinol (Lausanne); 2020; 11():502. PubMed ID: 32982960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone disorders in human immunodeficiency virus infection.
    Glesby MJ
    Clin Infect Dis; 2003; 37 Suppl 2():S91-5. PubMed ID: 12942380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone disease in HIV infection.
    Saccomanno MF; Ammassari A
    Clin Cases Miner Bone Metab; 2011 Jan; 8(1):33-6. PubMed ID: 22461801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review.
    Brown TT; Qaqish RB
    AIDS; 2006 Nov; 20(17):2165-74. PubMed ID: 17086056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications & side effects. HAART and bones-mixed messages.
    TreatmentUpdate; 2007; 19(4):3-5. PubMed ID: 17969257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.